[
  {
    "ts": "2025-07-26T02:40:31+00:00",
    "headline": "Vertex Pharmaceuticals Incorporated (VRTX) Launches JOURNAVX, First Non-Opioid Acute Pain Treatment",
    "summary": "We recently compiled a list of 10 Most Undervalued Healthcare Stocks to Buy According to Analysts. Vertex Pharmaceuticals Incorporated stands second on our list and has recently launched the first non opioid acute pain treatment. Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX), a global biotech firm based in Boston, is known for developing innovative treatments for serious diseases […]",
    "url": "https://finance.yahoo.com/news/vertex-pharmaceuticals-incorporated-vrtx-launches-024031583.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "8bf2b5ed-a37d-3305-b571-06fb4c812d87",
      "content": {
        "id": "8bf2b5ed-a37d-3305-b571-06fb4c812d87",
        "contentType": "STORY",
        "title": "Vertex Pharmaceuticals Incorporated (VRTX) Launches JOURNAVX, First Non-Opioid Acute Pain Treatment",
        "description": "",
        "summary": "We recently compiled a list of 10 Most Undervalued Healthcare Stocks to Buy According to Analysts. Vertex Pharmaceuticals Incorporated stands second on our list and has recently launched the first non opioid acute pain treatment. Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX), a global biotech firm based in Boston, is known for developing innovative treatments for serious diseases […]",
        "pubDate": "2025-07-26T02:40:31Z",
        "displayTime": "2025-07-26T02:40:31Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/ae3aff8170c32ab72e21b7d307dd751f",
          "originalWidth": 1456,
          "originalHeight": 816,
          "caption": "Vertex Pharmaceuticals Incorporated (VRTX) Launches JOURNAVX, First Non-Opioid Acute Pain Treatment ",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/QJoE63tFdMpnnrAbqprcaw--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/ae3aff8170c32ab72e21b7d307dd751f.cf.webp",
              "width": 1456,
              "height": 816,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Gi43WiQpLk0J.NMrpOdajw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/ae3aff8170c32ab72e21b7d307dd751f.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/vertex-pharmaceuticals-incorporated-vrtx-launches-024031583.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/vertex-pharmaceuticals-incorporated-vrtx-launches-024031583.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "VRTX"
            },
            {
              "symbol": "PINC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]